NASDAQ:XRAY - Nasdaq - US24906P1093 - Common Stock - Currency: USD
DENTSPLY SIRONA INC
NASDAQ:XRAY (1/23/2025, 8:34:09 PM)
After market: 19.44 0 (0%)19.44
+0.08 (+0.41%)
The current stock price of XRAY is 19.44 USD. In the past month the price increased by 3.96%. In the past year, price decreased by -44.33%.
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ("Dentsply" or the...
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of...
/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed...
RADNOR, PA - January 22, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.51 | 44.53B | ||
COO | COOPER COS INC/THE | 25.86 | 19.10B | ||
ALGN | ALIGN TECHNOLOGY INC | 25.2 | 17.53B | ||
SOLV | SOLVENTUM CORP | 17.69 | 12.72B | ||
LNTH | LANTHEUS HOLDINGS INC | 14.07 | 6.79B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 30.85 | 6.04B | ||
BLCO | BAUSCH + LOMB CORP | 27.62 | 5.93B | ||
ICUI | ICU MEDICAL INC | 29.42 | 4.09B | ||
HAE | HAEMONETICS CORP/MASS | 17.86 | 3.66B | ||
NEOG | NEOGEN CORP | 29.35 | 2.54B | ||
UFPT | UFP TECHNOLOGIES INC | 37.45 | 2.01B | ||
RXST | RXSIGHT INC | N/A | 1.31B |
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The company develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
DENTSPLY SIRONA INC
Suite 60W, 221 West Philadelphia Street
York PENNSYLVANIA 28277 US
CEO: Donald M. Casey
Employees: 15000
Company Website: https://www.dentsplysirona.com/
Investor Relations: https://investor.dentsplysirona.com
Phone: 18445463722
The current price of XRAY is 19.44 USD.
The exchange symbol of DENTSPLY SIRONA INC is XRAY and it is listed on the Nasdaq exchange.
XRAY is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for XRAY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of XRAY.
XRAY has a dividend yield of 3.47%. The yearly dividend amount is currently 0.55.
The PE ratio for XRAY is 10.51. This is based on the reported non-GAAP earnings per share of 1.85 and the current share price of 19.44 USD.
The outstanding short interest for XRAY is 4.97% of its float.
ChartMill assigns a technical rating of 2 / 10 to XRAY. When comparing the yearly performance of all stocks, XRAY is a bad performer in the overall market: 91.3% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to XRAY. XRAY has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months XRAY reported a non-GAAP Earnings per Share(EPS) of 1.85. The EPS increased by 0% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -6.23% | ||
ROE | -16.58% | ||
Debt/Equity | 0.72 |
ChartMill assigns a Buy % Consensus number of 75% to XRAY. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 2.38% and a revenue growth -2.9% for XRAY